Q1 2016 13F Holders as of 31 Mar 2016
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
8,165,808
-
Total 13F shares
-
19,798,948
-
Share change
-
+535,181
-
Total reported value
-
$376,742,000
-
Put/Call ratio
-
0%
-
Price per share
-
$19.03
-
Number of holders
-
68
-
Value change
-
+$7,108,410
-
Number of buys
-
36
-
Number of sells
-
34
Institutional Holders of Atara Biotherapeutics, Inc. - Common Stock (ATRA) as of Q1 2016
As of 31 Mar 2016,
Atara Biotherapeutics, Inc. - Common Stock (ATRA) was held by
68 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
19,798,948 shares.
The largest 10 holders included
BAUPOST GROUP LLC/MA, FMR LLC, Redmile Group, LLC, UBS ASSET MANAGEMENT AMERICAS INC, EAGLE ASSET MANAGEMENT INC, Arrowpoint Asset Management, LLC, BlackRock Fund Advisors, BRIDGER MANAGEMENT, LLC, Visium Asset Management, LP, and VANGUARD GROUP INC.
This page lists
68
institutional shareholders reporting positions in this security
for the Q1 2016 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.